在门外科手术期间,手术内无心脏起器植入的长期安全性和有效性
Connor P Oates1, Karel T N Breeman2, Marc A Miller1
1Helmsley Electrophysiology Center, Department of Cardiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
JACC. Clinical electrophysiology
|August 17, 2024
概括
在门手术期间,无心脏起器 (LCP) 的术内植入是安全有效的. 这种新的方法提供了可靠的永久节奏,在随访期间没有观察到设备并发症.
科学领域:
- 心脏病学 心脏病学
- 心脏外科手术 心脏外科手术
- 生物医学工程 生物医学工程
背景情况:
- 在心脏手术期间直接可视化和植入无心脏起器 (LCP) 为需要节奏的患者提供了一种新方法.
- 这一策略特别适用于患有术后导电问题的高风险的患者或接受门手术的现有节奏需求的患者.
研究的目的:
- 在连续100名患者中评估在门手术期间植入LCP的长期安全性和有效性.
主要方法:
- 一项回顾性,单中心的队列研究包括100名在门手术期间接受手术内LCP植入的患者.
- 安全性和有效性通过植入时的评估和随后的后续访问来评估.
主要成果:
- 所有100名患者 (平均年龄68岁) 都接受了LCP,主要是在三膜手术期间 (99%) 和经常作为多膜手术的一部分 (78%).
- 指示包括高风险的心房静脉阻塞 (54%) 和先前存在的肌节律 (46%).
- 在平均10.6个月的随访期间,没有出现与设备相关的并发症,95%的患者在12个月后保持了可接受的节奏值.
结论:
- 在直接可视化下进行手术期间的LCP植入是进行门手术的患者永久节奏的安全有效策略.
- 这些LCP的术后电气性能与皮肤穿植入的电气性能相当.
相关概念视频
01:28Kidney Transplant I: Introduction
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
01:26Kidney Transplant II: Surgical Procedure
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...